Top

Published in:

01-04-2018

A systematic review of ultrasound-accelerated catheter-directed thrombolysis in the treatment of deep vein thrombosis

Authors: Yadong Shi, Wanyin Shi, Liang Chen, Jianping Gu

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2018

Abstract

To review the clinical evidence for ultrasound-accelerated catheter-directed thrombolysis (UACDT) using the EKOS system in the treatment of deep vein thrombosis (DVT) in terms of case selection, procedural outcomes, clinical outcomes and safety outcomes. A systematic literature search strategy was used to identify the use of the EKOS system in the treatment of DVT using the following electronic databases: MEDLINE, EMBASE, the Cochrane databases and the Web of Science. The references in the relevant literature were also screened. Our literature search identified a total of 16 unique clinical studies. Twelve of the sixteen studies were retrospective case series studies. To date, only one randomised controlled trial (RCT) is available. Overall, UACDT using the EKOS system was performed 548 times in 512 patients. Among all cases, 77–100% achieved substantial lysis (> 50%) based on the different definitions of the individual studies. This treatment modality appears to be safe, as there were no reported procedure-related pulmonary embolisms (PE) and only one procedure-related death was reported. Bleeding events were reported in 14 of the 16 studies, and 3.9% (20/512) of the cases of bleeding were considered major. During the follow-up, post-thrombotic syndrome was observed in 17.1% (20/117) of cases. UACDT using the EKOS system is an effective, safe and promising treatment modality for DVT, but the existing clinical evidence is inadequate to make UACDT using the EKOS system the first-line choice for DVT. Additional prospective large-sample RCTs with long-term follow-ups are warranted to define the role of UACDT using the EKOS system in the treatment of DVT.

Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA (2014) Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985–2009). Am J Med 127(9):829–839 e825. https://doi.org/10.1016/j.amjmed.2014.03.041 CrossRefPubMedPubMedCentral

Mannucci PM, Poller L (2001) Venous thrombosis and anticoagulant therapy. Br J Haematol 114(2):258–270CrossRefPubMed

Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149(2):315–352. https://doi.org/10.1016/j.chest.2015.11.026 CrossRefPubMed

Baldwin MJ, Moore HM, Rudarakanchana N, Gohel M, Davies AH (2013) Post-thrombotic syndrome: a clinical review. J Thromb Haemost 11(5):795–805. https://doi.org/10.1111/jth.12180 CrossRefPubMed

Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, Gupta DK, Prandoni P, Vedantham S, Walsh ME, Weitz JI, American Heart Association Council on Peripheral Vascular Disease CoCC, Council on C, Stroke N (2014) The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 130(18):1636–1661. https://doi.org/10.1161/CIR.0000000000000130 CrossRefPubMed

Roberts LN, Patel RK, Donaldson N, Bonner L, Arya R (2014) Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis. Haematologica 99(3):e41–e43. https://doi.org/10.3324/haematol.2013.089870 CrossRefPubMedPubMedCentral

Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Lohr JM, McLafferty RB, Murad MH, Padberg F, Pappas P, Raffetto JD, Wakefield TW, Society for Vascular S, American Venous F (2012) Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 55(5):1449–1462. https://doi.org/10.1016/j.jvs.2011.12.081 CrossRefPubMed

Enden T, Haig Y, Klow NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM, CaVen TSG (2012) Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 379(9810):31–38. https://doi.org/10.1016/S0140-6736(11)61753-4 CrossRefPubMed

Haig Y, Enden T, Grotta O, Klow NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbaek G, Sandset PM, CaVen TSG (2016) Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol 3(2):e64–e71. https://doi.org/10.1016/S2352-3026(15)00248-3 CrossRefPubMed

10.

Watson L, Broderick C, Armon MP (2014) Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 1(1):CD002783. https://doi.org/10.1002/14651858.CD002783.pub3

11.

Trubestein G, Engel C, Etzel F, Sobbe A, Cremer H, Stumpff U (1976) Thrombolysis by ultrasound. Clin Sci Mol Med Suppl 3:697s–698sPubMed

12.

Francis CW, Suchkova VN (2001) Ultrasound and thrombolysis. Vasc Med 6(3):181–187CrossRefPubMed

13.

Doomernik DE, Schrijver AM, Zeebregts CJ, de Vries JP, Reijnen MM (2011) Advancements in catheter-directed ultrasound-accelerated thrombolysis. J Endovasc Ther 18(3):418–434. https://doi.org/10.1583/10-3362.1 CrossRefPubMed

14.

Francis CW, Blinc A, Lee S, Cox C (1995) Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 21(3):419–424CrossRefPubMed

15.

Sakharov DV, Hekkenberg RT, Rijken DC (2000) Acceleration of fibrinolysis by high-frequency ultrasound: the contribution of acoustic streaming and temperature rise. Thromb Res 100(4):333–340CrossRefPubMed

16.

Weiss HL, Selvaraj P, Okita K, Matsumoto Y, Voie A, Hoelscher T, Szeri AJ (2013) Mechanical clot damage from cavitation during sonothrombolysis. J Acoust Soc Am 133(5):3159–3175. https://doi.org/10.1121/1.4795774 CrossRefPubMed

17.

Datta S, Coussios CC, Ammi AY, Mast TD, de Courten-Myers GM, Holland CK (2008) Ultrasound-enhanced thrombolysis using definity as a cavitation nucleation agent. Ultrasound Med Biol 34(9):1421–1433. https://doi.org/10.1016/j.ultrasmedbio.2008.01.016 CrossRefPubMedPubMedCentral

18.

Sutton JT, Haworth KJ, Pyne-Geithman G, Holland CK (2013) Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv 10(5):573–592. https://doi.org/10.1517/17425247.2013.772578 CrossRefPubMedPubMedCentral

19.

Olsson SB, Johansson B, Nilsson AM, Olsson C, Roijer A (1994) Enhancement of thrombolysis by ultrasound. Ultrasound Med Biol 20(4):375–382CrossRefPubMed

20.

Hitchcock KE, Ivancevich NM, Haworth KJ, Caudell Stamper DN, Vela DC, Sutton JT, Pyne-Geithman GJ, Holland CK (2011) Ultrasound-enhanced rt-PA thrombolysis in an ex vivo porcine carotid artery model. Ultrasound Med Biol 37(8):1240–1251. https://doi.org/10.1016/j.ultrasmedbio.2011.05.011 CrossRefPubMedPubMedCentral

21.

Luo H, Birnbaum Y, Fishbein MC, Peterson TM, Nagai T, Nishioka T, Siegel RJ (1998) Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res 89(4):171–177CrossRefPubMed

22.

Soltani A, Singhal R, Garcia JL, Raju NR (2007) Absence of biological damage from prolonged exposure to intravascular ultrasound: a swine model. Ultrasonics 46(1):60–67. https://doi.org/10.1016/j.ultras.2006.10.004 CrossRefPubMed

23.

Ganguli S, Kalva S, Oklu R, Walker TG, Datta N, Grabowski EF, Wicky S (2012) Efficacy of lower-extremity venous thrombolysis in the setting of congenital absence or atresia of the inferior vena cava. Cardiovasc Intervent Radiol 35(5):1053–1058. https://doi.org/10.1007/s00270-011-0247-2 CrossRefPubMed

24.

Stanley GA, Murphy EH, Plummer MM, Chung J, Modrall JG, Arko FR 3rd (2013) Midterm results of percutaneous endovascular treatment for acute and chronic deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 1 (1):52–58. https://doi.org/10.1016/j.jvsv.2012.04.002 CrossRefPubMed

25.

Stuck AK, Engelberger RP, Saengprakai W, Kucher N (2016) Pharmacomechanical or ultrasound-assisted thrombolysis, balloon angioplasty and provisional surgical decompression for upper extremity deep vein thrombosis due to thoracic outlet syndrome. Thromb Res 145:109–111. https://doi.org/10.1016/j.thromres.2016.08.006 CrossRefPubMed

26.

Kasirajan KM (2008) Ultrasound enhanced thrombolysis with the EKOS System for acute limb ischemia and DVT. Paper presented at the 35th annual VEITH symposium, New York, NY, USA, November 19–23

27.

Raabe RA (2006) Ultrasound facilitated thrombolysis in treating DVT. Rapid and complete clot clearance using EKOS Lysus system offers promising treatment for DVT. Endovascular Today 4:1–14

28.

Motarjeme A (2007) Ultrasound-enhanced thrombolysis. J Endovasc Ther 14(2):251–256. https://doi.org/10.1177/152660280701400218 CrossRefPubMed

29.

Parikh S, Motarjeme A, McNamara T, Raabe R, Hagspiel K, Benenati JF, Sterling K, Comerota A (2008) Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience. J Vasc Interv Radiol 19(4):521–528. https://doi.org/10.1016/j.jvir.2007.11.023 CrossRefPubMed

30.

Raabe RD (2010) Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects. J Vasc Interv Radiol 21(8):1165–1172. https://doi.org/10.1016/j.jvir.2010.03.020 CrossRefPubMed

31.

Grommes J, Strijkers R, Greiner A, Mahnken AH, Wittens CH (2011) Safety and feasibility of ultrasound-accelerated catheter-directed thrombolysis in deep vein thrombosis. Eur J Vasc Endovasc Surg 41(4):526–532. https://doi.org/10.1016/j.ejvs.2010.11.035 CrossRefPubMed

32.

Dumantepe M, Tarhan A, Yurdakul I, Ozler A (2013) US-accelerated catheter-directed thrombolysis for the treatment of deep venous thrombosis. Diagn Interv Radiol 19(3):251–258. https://doi.org/10.5152/dir.2012.004 PubMed

33.

Ozcinar E, Yaman ND, Cakici M, Baran C, Inan MB, Durdu S, Akar R, Sirlak M (2017) Pharmacomechanical thrombectomy of upper extremity deep vein thrombosis. Int Angiol 36(3):275–280. https://doi.org/10.23736/S0392-9590.16.03749-4 PubMed

34.

Baker R, Samuels S, Benenati JF, Powell A, Uthoff H (2012) Ultrasound-accelerated vs standard catheter-directed thrombolysis: a comparative study in patients with iliofemoral deep vein thrombosis. J Vasc Interv Radiol 23(11):1460–1466. https://doi.org/10.1016/j.jvir.2012.08.008 CrossRefPubMed

35.

Dumantepe M, Tarhan IA, Ozler A (2013) Treatment of chronic deep vein thrombosis using ultrasound accelerated catheter-directed thrombolysis. Eur J Vasc Endovasc Surg 46(3):366–371. https://doi.org/10.1016/j.ejvs.2013.05.019 CrossRefPubMed

36.

Strijkers RH, Grommes J, Arnoldussen CW, de Graaf R, Ten Cate AJ, Wittens CH (2013) Ultrasound-accelerated catheter-directed thrombolysis in acute iliofemoral deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 1(3):225–230. https://doi.org/10.1016/j.jvsv.2012.10.063 CrossRefPubMed

37.

Engelberger RP, Fahrni J, Willenberg T, Baumann F, Spirk D, Diehm N, Do DD, Baumgartner I, Kucher N (2014) Fixed low-dose ultrasound-assisted catheter-directed thrombolysis followed by routine stenting of residual stenosis for acute ilio-femoral deep-vein thrombosis. Thromb Haemost 111(6):1153–1160. https://doi.org/10.1160/TH13-11-0932 CrossRefPubMed

38.

Engelberger RP, Spirk D, Willenberg T, Alatri A, Do DD, Baumgartner I, Kucher N (2015) Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 8(1):e002027–e002027. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002027 CrossRefPubMed

39.

Strijkers RH, de Wolf MA, Arnoldussen CW, Timbergen MJ, de Graaf R, ten Cate-Hoek AJ, Wittens CH (2015) Venous in-stent thrombosis treated by ultrasound accelerated catheter directed thrombolysis. Eur J Vasc Endovasc Surg 49(4):440–447. https://doi.org/10.1016/j.ejvs.2015.01.006 CrossRefPubMed

40.

Tichelaar VY, Brodin EE, Vik A, Isaksen T, Skjeldestad FE, Kumar S, Trasti NC, Singh K, Hansen JB (2016) A retrospective comparison of ultrasound-assisted catheter-directed thrombolysis and catheter-directed thrombolysis alone for treatment of proximal deep vein thrombosis. Cardiovasc Intervent Radiol 39(8):1115–1121. https://doi.org/10.1007/s00270-016-1367-5 CrossRefPubMedPubMedCentral

41.

Zaghlool DS, Franz RW, Jenkins J (2016) EkoSonic thrombolysis as a therapeutic adjunct in venous occlusive disease. Int J Angiol 25(4):203–209. https://doi.org/10.1055/s-0036-1580698 CrossRefPubMedPubMedCentral

42.

Lu T, Loh TM, El-Sayed HF, Davies MG (2017) Single-center retrospective review of ultrasound-accelerated versus traditional catheter-directed thrombolysis for acute lower extremity deep venous thrombosis. Vascular 25(5):525–532. https://doi.org/10.1177/1708538117702061 CrossRefPubMed

43.

Dharmarajah B, Sounderajah V, Rowland SP, Leen EL, Davies AH (2015) Aging techniques for deep vein thrombosis: a systematic review. Phlebology 30(2):77–84. https://doi.org/10.1177/0268355514528691 CrossRefPubMed

44.

Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH (1999) Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 211(1):39–49. https://doi.org/10.1148/radiology.211.1.r99ap4739 CrossRefPubMed

45.

Vedantham S, Grassi CJ, Ferral H, Patel NH, Thorpe PE, Antonacci VP, Janne d’Othee BM, Hofmann LV, Cardella JF, Kundu S, Lewis CA, Schwartzberg MS, Min RJ, Sacks D, Technology Assessment Committee of the Society of Interventional R (2009) Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 20 (7 Suppl):S391–S408. https://doi.org/10.1016/j.jvir.2009.04.034 CrossRefPubMed

46.

Vedantham S, Sista AK, Klein SJ, Nayak L, Razavi MK, Kalva SP, Saad WE, Dariushnia SR, Caplin DM, Chao CP, Ganguli S, Walker TG, Nikolic B, Society of Interventional R, Cardiovascular, Interventional Radiological Society of Europe Standards of Practice C (2014) Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 25(9):1317–1325. https://doi.org/10.1016/j.jvir.2014.04.019 CrossRefPubMed

47.

Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, Subcommittee on Control of Anticoagulation of the S., Standardization Committee of the International Society on T, Haemostasis (2009) Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 7(5):879–883. https://doi.org/10.1111/j.1538-7836.2009.03294.x CrossRefPubMed

48.

Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihaemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:629–694

49.

investigators G (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329(10):673–682. https://doi.org/10.1056/NEJM199309023291001 CrossRef

50.

Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N, Natarajan K, Rundback J, Sadiq IR, Liu SK, Bhalla N, Raja ML, Weinstock BS, Cynamon J, Elmasri FF, Garcia MJ, Kumar M, Ayerdi J, Soukas P, Kuo W, Liu PY, Goldhaber SZ, Investigators SI (2015) A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: The SEATTLE II study. JACC Cardiovasc Interv 8(10):1382–1392. https://doi.org/10.1016/j.jcin.2015.04.020 CrossRefPubMed

51.

Kucher N, Boekstegers P, Muller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, Tebbe U, Horstkotte J, Muller R, Blessing E, Greif M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Hartel D, Grunwald H, Empen K, Baumgartner I (2014) Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 129(4):479–486. https://doi.org/10.1161/CIRCULATIONAHA.113.005544 CrossRefPubMed

52.

Schrijver AM, van Leersum M, Fioole B, Reijnen MM, Hoksbergen AW, Vahl AC, de Vries JP (2015) Dutch randomized trial comparing standard catheter-directed thrombolysis and ultrasound-accelerated thrombolysis for arterial thromboembolic infrainguinal disease (DUET). J Endovasc Ther 22(1):87–95. https://doi.org/10.1177/1526602814566578 CrossRefPubMed

53.

Barlinn K, Tsivgoulis G, Barreto AD, Alleman J, Molina CA, Mikulik R, Saqqur M, Demchuk AM, Schellinger PD, Howard G, Alexandrov AV (2014) Outcomes following sonothrombolysis in severe acute ischemic stroke: subgroup analysis of the CLOTBUST trial. Int J Stroke 9(8):1006–1010. https://doi.org/10.1111/ijs.12340 CrossRefPubMedPubMedCentral

54.

Lang EV, Kulis AM, Villani M, Barnhart W, Balano R, Cohen R (2008) Hemolysis comparison between the OmniSonics OmniWave endovascular system and the Possis AngioJet in a porcine model. J Vasc Interv Radiol 19(8):1215–1221. https://doi.org/10.1016/j.jvir.2008.04.007 CrossRefPubMed

55.

Schleicher N, Tomkins AJ, Kampschulte M, Hyvelin JM, Botteron C, Juenemann M, Yeniguen M, Krombach GA, Kaps M, Spratt NJ, Gerriets T, Nedelmann M (2016) Sonothrombolysis with BR38 microbubbles improves microvascular patency in a rat model of stroke. PLoS ONE 11(4):e0152898. https://doi.org/10.1371/journal.pone.0152898 CrossRefPubMedPubMedCentral

56.

Hua X, Zhou L, Liu P, He Y, Tan K, Chen Q, Gao Y, Gao Y (2014) In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model. J Thromb Thrombolysis 38(1):57–64. https://doi.org/10.1007/s11239-014-1071-8 CrossRefPubMed

57.

Wu J, Xie F, Lof J, Sayyed S, Porter TR (2015) Utilization of modified diagnostic ultrasound and microbubbles to reduce myocardial infarct size. Heart 101(18):1468–1474. https://doi.org/10.1136/heartjnl-2015-307625 CrossRefPubMed

58.

Blinc A, Francis CW, Trudnowski JL, Carstensen EL (1993) Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 81(10):2636–2643PubMed

59.

Braaten JV, Goss RA, Francis CW (1997) Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 78(3):1063–1068PubMed

60.

Grunwald MR, Hofmann LV (2004) Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 15(4):347–352CrossRefPubMed

61.

Karthikesalingam A, Young EL, Hinchliffe RJ, Loftus IM, Thompson MM, Holt PJ (2011) A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Eur J Vasc Endovasc Surg 41(4):554–565. https://doi.org/10.1016/j.ejvs.2011.01.010 CrossRefPubMed

62.

Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW (1998) Binding of tissue-plasminogen activator to fibrin: effect of ultrasound. Blood 91(6):2019–2025PubMed

Title: A systematic review of ultrasound-accelerated catheter-directed thrombolysis in the treatment of deep vein thrombosis
Authors: Yadong Shi
Wanyin Shi
Liang Chen
Jianping Gu
Publication date: 01-04-2018
Publisher: Springer US
Published in: Journal of Thrombosis and Thrombolysis / Issue 3/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-018-1629-y

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy

Novel oral anticoagulants in the preoperative period: a meta-analysis

TV viewing and incident venous thromboembolism: the Atherosclerotic Risk in Communities Study

A new method of CT for the cardiac measurement: correlation of computed tomography measured cardiac parameters and pulmonary obstruction index to assess cardiac morphological changes in acute pulmonary embolism patients

A rare CALR variant mutation and a review of CALR in essential thrombocythemia

Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage